Update on the medical treatment of metastatic renal cell carcinoma.
about
Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancerQuantification of HLA class I molecules on renal cell carcinoma using Edman degradationMetastatic tumors to the pancreas: The role of surgery.Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression.Neo adjuvant treatment with targeted molecules for renal cell cancer in current clinical practise.Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinoma.Targeted therapy and hand-foot skin reaction in advanced renal cell carcinoma.Can the Leibovich score for clear cell renal cell carcinoma (ccRCC) be accurately reported by a general pathologist?Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway.Optical spectroscopy techniques can accurately distinguish benign and malignant renal tumours.The Role of Angiogenesis in the Persistence of Chemoresistance in Epithelial Ovarian Cancer.Pancreatic metastases: An increasing clinical entityA late recurrence of renal cell carcinoma as pancreatic metastases: a rare disease.Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma.Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitors.
P2860
Q27853378-B684ED98-9CC9-4739-AF69-62D41A3C34EDQ28072655-28867824-7F19-4AF3-A690-8C508CD2BE6DQ33798689-49DA264C-405A-46E6-B380-38878BF13B78Q34443793-703E3286-5707-4923-8676-BBC6FF045FC0Q35535686-FDE43FF3-D958-43BD-9AE5-6A298ED87F16Q36084067-9F24D704-2735-4D3C-9070-22CF0D5E52E9Q37508003-77623C6C-5CE5-4742-9C88-D9D084A0F570Q37683755-EBFBE009-C7B8-43AB-B7C0-8EDFCEF5FB00Q38140025-3142E80E-4235-4B77-B02A-F95AAFCE6A64Q38160090-678E1DA2-B473-4A46-A58A-9A053535A0F3Q39560782-B30BC1E2-D730-47CA-87EC-09AE37D8E11AQ39815570-723A49D1-D199-4F84-9B75-4874213AF732Q41129517-4D95DA9F-879D-4BF8-A760-DEBD5FB193C5Q41361229-2730558C-9BF9-435A-AB18-87813086E956Q48492118-01F1A5D5-C7C9-4CA6-B137-DE4569BC7656Q52896102-BE461408-25DF-4950-B501-7EFF586E5F21
P2860
Update on the medical treatment of metastatic renal cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update on the medical treatment of metastatic renal cell carcinoma.
@en
Update on the medical treatment of metastatic renal cell carcinoma.
@nl
type
label
Update on the medical treatment of metastatic renal cell carcinoma.
@en
Update on the medical treatment of metastatic renal cell carcinoma.
@nl
prefLabel
Update on the medical treatment of metastatic renal cell carcinoma.
@en
Update on the medical treatment of metastatic renal cell carcinoma.
@nl
P2093
P50
P1433
P1476
Update on the medical treatment of metastatic renal cell carcinoma.
@en
P2093
Hervé Wallerand
Karim Bensalah
Patricia Fergelot
Stéphane Culine
P304
P356
10.1016/J.EURURO.2008.04.056
P407
P577
2008-05-05T00:00:00Z